The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer: Commentary re: J. Kwong et al., Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer res., 8: 131-137, 2002, and H-Z. Zou et al., Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer res., 8: 188-191, 2002

Clinical Cancer Research

Volumn 8, Issue 1, 2002, Pages 17-21

  Widschwendter, Martin ^a   Jones, Peter A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CASPASE 8; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; INTERFERON; RETINOID; TUMOR NECROSIS FACTOR ALPHA;

AGING; APOPTOSIS; CANCER; CELL CYCLE; CHEMOPROPHYLAXIS; CHEMOSENSITIVITY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; EARLY DIAGNOSIS; EPITHELIUM; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION; GENE SILENCING; HUMANS; MICROSATELLITE REPEATS; MUTATION; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROMOTER REGIONS (GENETICS); SURVIVAL RATE;

EID: 0036154815     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (41)

1. Promoter hypermethylation of multiple genes in Nasopharyngeal carcinoma
2. Detection of aberrant p16 methylation in the serum of colorectal cancer patients
3. DNA methylation errors and cancer
4. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
5. The role of DNA methylation in mammalian epigenetics
6. The DNA methylation paradox
7. Cancer epigenetics comes of age
8. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors
9. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: Possible implications for role as tumor suppressor gene
10. Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors
11. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer
12. Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer
13. Accelerated age-related CpG island methylation in ulcerative colitis
14. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development
15. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands
16. Identifying 5-methylcytosine and related modifications in DNA genomes
17. Low frequency of p16/CDKN2A methylation in sporadic melanoma: Comparative approaches for methylation analysis of primary tumors
18. Methylation-specific PCR, a novel PCR assay for methylation status of CpG islands
19. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)
20. COBRA: A sensitive and quantitative DNA methylation assay
21. MethyLight: A high-throughput assay to measure DNA methylation
22. Epigenetic patterns in the progression of esophageal adenocarcinoma
23. Molecular portraits of human breast tumours
24. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer
25. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
26. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer
27. Methylation of p15 and p16 genes in acute promyelocytic leukemia: Potential diagnostic and prognostic significance
28. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma
29. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: Clinical outcome during long-term follow-up
30. Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time
31. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
32. Detecting colorectal cancer in stool with the use of multiple genetic targets
33. Predicting lung cancer by detecting aberrant promoter methylation in sputum
34. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids
35. Methylation profiling of human cancers in blood: Molecular monitoring and prognostication
36. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine
37. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation
38. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines
39. Retinoid-interferon therapy of solid tumors
40. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: Role in response to chemoprevention and cancer development
41. Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients